CIDRAP newsletters options
In a joint statement today the World Health Organization (WHO) and South Korean health officials issued public health recommendations for people attending the upcoming winter Olympic and Paralympic Games in Pyeongchang.
An online survey of frontline prescribers found mostly positive attitudes toward antimicrobial stewardship programs (ASPs) but also identified several specific deficiencies related to knowledge, prescribing practices, and awareness of available resources, according to a study yesterday in Infection Control and Hospital Epidemiology.
Since July 2012, the FDA has approved 12 products that are now on the market.
Flu activity is still high in the Northern Hemisphere's temperate-zone countries, with a few countries now reporting hospitalization and intensive care unit admission levels that top previous seasons, the World Health Organization (WHO) said yesterday in its latest global flu update. Adults ages 65 and older are the hardest hit groups in both Canada and the United States.
The Infectious Diseases Society of America (IDSA) today released a letter urging Congress to provide new economic incentives for the development of new antimicrobial drugs.
The findings undermine the country's efforts to combat rising antibiotic resistance.
One study hints that infection in children and young adults may affect brain health.
Today the French pharmaceutical company, Sanofi Pasteur, said they would not pay the Philippines millions of dollars in return for Dengvaxia vaccines, after the country halted a national vaccination program in light of concerns the vaccine can cause severe infection in dengue-immune recipients.
The United States, Brazil, Argentina, and now Canada, have all reported cases of cephalosporin-resistant gonorrhea, according to the latest situation report published by the Pan American Health organization (PAHO).
Strains with key drug-resistance genes grew from 16% of samples in 2008 to 68% in 2013.
By every metric, this H3N2-dominated season is measuring up as a bad one.
Allergan, a pharmaceutical company based in Dublin, Ireland, yesterday announced that the US Food and Drug Administration (FDA) has approved an expanded indication for its antibiotic combination drug Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by gram-negative organisms.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The Global Polio Eradication Initiative (GPEI) has received early reports of two new wild poliovirus type 1 (WPV1) cases, both in Kandahar province, GPEI said in its weekly update today.
Protection against the H3N2 strain was 17%—and not statistically significant.
A new report from Brazil's Ministry of Health showed a steady rise in the number of yellow fever cases confirmed and suspected since an update posted last week. There are now 213 confirmed cases, 83 more than last week, and 1,080 suspected cases, an increase of 479 since the previous report.
A new story by the UK-based Bureau of Investigative Journalism alleges the last-resort antibiotic colistin is being widely used on Indian poultry farms, despite worldwide concerns that using the drug in food-producing animals could render it ineffective.
Multiple factors may affect antibiotic overprescribing.
It's too soon to know if the study applies to people, but West Nile caused fetal brain damage and death in mice.
Recent gains in preventing the disease in pregnancy may be lost as resistance to prophylactic treatment rises.
